Phase III, randomized, double-blind, placebo-comparative study to evaluate the efficacy and safety of a single intra-articular injection of RTX-GRT7039 in adult patients with pain derived from gonarthrosis.
CLINICAL TRIAL WITH MEDICINES
Clinical trial information
- Promoter: GRÜNENTHAL GMBH
- Phase: III
- Execution start: 23/11/2022
- End of execution: 30/09/2024
- PI: RAFAEL GALVEZ MATEOS